1. Home
  2. INM vs SKYH Comparison

INM vs SKYH Comparison

Compare INM & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • SKYH
  • Stock Information
  • Founded
  • INM 1981
  • SKYH 2017
  • Country
  • INM Canada
  • SKYH United States
  • Employees
  • INM N/A
  • SKYH N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • SKYH Military/Government/Technical
  • Sector
  • INM Health Care
  • SKYH Industrials
  • Exchange
  • INM Nasdaq
  • SKYH Nasdaq
  • Market Cap
  • INM 3.2M
  • SKYH N/A
  • IPO Year
  • INM N/A
  • SKYH N/A
  • Fundamental
  • Price
  • INM $3.00
  • SKYH $10.95
  • Analyst Decision
  • INM
  • SKYH Strong Buy
  • Analyst Count
  • INM 0
  • SKYH 2
  • Target Price
  • INM N/A
  • SKYH $15.25
  • AVG Volume (30 Days)
  • INM 56.6K
  • SKYH 205.1K
  • Earning Date
  • INM 05-13-2025
  • SKYH 05-13-2025
  • Dividend Yield
  • INM N/A
  • SKYH N/A
  • EPS Growth
  • INM N/A
  • SKYH N/A
  • EPS
  • INM N/A
  • SKYH N/A
  • Revenue
  • INM $4,832,013.00
  • SKYH $14,761,000.00
  • Revenue This Year
  • INM N/A
  • SKYH $122.85
  • Revenue Next Year
  • INM N/A
  • SKYH $61.16
  • P/E Ratio
  • INM N/A
  • SKYH N/A
  • Revenue Growth
  • INM N/A
  • SKYH 94.86
  • 52 Week Low
  • INM $1.72
  • SKYH $8.26
  • 52 Week High
  • INM $15.70
  • SKYH $14.52
  • Technical
  • Relative Strength Index (RSI)
  • INM 62.76
  • SKYH 45.76
  • Support Level
  • INM $2.56
  • SKYH $10.34
  • Resistance Level
  • INM $3.05
  • SKYH $11.36
  • Average True Range (ATR)
  • INM 0.27
  • SKYH 0.77
  • MACD
  • INM 0.09
  • SKYH -0.09
  • Stochastic Oscillator
  • INM 92.98
  • SKYH 28.02

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Share on Social Networks: